Soluble LAG3 has been evaluated in different studies, demonstrating a predictive value of prognosis in several solid tumors, including gastric and breast cancer [33,34], primary liver cancer [35], non-small cell lung cancer (NSCLC), and clear cell carcinoma [36]. This evidence concerns the gene LAG3 and clear cell adenocarcinoma.